C07D 277/42
Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
C07D277/42 (Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals) appears on 597 US grants and 528 published applications in this corpus.
Search patents in C07D- Granted patents
- 597
- Published applications
- 528
- Assignees
- 342
- Inventors
- 1,914
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 4 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 7 | 0 |
| 1982 | 6 | 0 |
| 1983 | 14 | 0 |
| 1984 | 6 | 0 |
| 1985 | 5 | 0 |
| 1986 | 5 | 0 |
| 1987 | 12 | 0 |
| 1988 | 8 | 0 |
| 1989 | 7 | 0 |
| 1990 | 10 | 0 |
| 1991 | 6 | 0 |
| 1992 | 11 | 0 |
| 1993 | 22 | 0 |
| 1994 | 5 | 0 |
| 1995 | 11 | 0 |
| 1996 | 14 | 0 |
| 1997 | 29 | 0 |
| 1998 | 11 | 0 |
| 1999 | 7 | 0 |
| 2000 | 7 | 0 |
| 2001 | 13 | 3 |
| 2002 | 13 | 16 |
| 2003 | 14 | 31 |
| 2004 | 14 | 37 |
| 2005 | 11 | 35 |
| 2006 | 12 | 31 |
| 2007 | 23 | 40 |
| 2008 | 19 | 30 |
| 2009 | 22 | 29 |
| 2010 | 25 | 27 |
| 2011 | 21 | 18 |
| 2012 | 18 | 21 |
| 2013 | 16 | 21 |
| 2014 | 23 | 21 |
| 2015 | 18 | 23 |
| 2016 | 20 | 19 |
| 2017 | 14 | 12 |
| 2018 | 13 | 13 |
| 2019 | 11 | 15 |
| 2020 | 9 | 12 |
| 2021 | 12 | 7 |
| 2022 | 6 | 16 |
| 2023 | 7 | 20 |
| 2024 | 15 | 14 |
| 2025 | 5 | 11 |
| 2026 | 6 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted aminothiazoles as DGKzeta inhibitors for immune activation7 Jul 2026US 12,673,927 B2Deutsches Krebsforschungszentrum
- Inhibitors of lysyl oxidases2 Jun 2026US 12,642,791 B2University of South Carolina
- Small molecule prostagladin transport inhibitors19 May 2026US 12,630,515 B2Albert Einstein College of Medicine
- Compounds for the treatment of neurodegenerative and metabolic disorders31 Mar 2026US 12,590,094 B2University of Florida Research Foundation, Inc.
- Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine24 Mar 2026US 12,582,634 B2Neurocrine Biosciences, Inc.
- Hiv-1p rotease inhibitors and uses thereof17 Sep 2026US 2026/0272926 A1Purdue Research Foundation
- Thiazole compounds as dgk¿ inhibitors17 Sep 2026US 2026/0274847 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Antibacterial and synergistic active compound and use thereof27 Aug 2026US 2026/0250257 A1East China University of Science and Technology
- Stable monohydrate of df2755a and process for its preparation19 Mar 2026US 2026/0076949 A1Dompé Farmaceutici S.P.A.
- Squaramide derivatives as cb1 allosteric modulators5 Mar 2026US 2026/0062376 A1Research Triangle Institute
Most cited
By later US patents
- Cephem derivative162US 4,278,793 AHoechst Aktiengesellschaft · 1981
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Novel compounds146US 5,002,953 ABeecham Group Limited · 1991
- Thiazole derivatives110US 6,720,427 B2Pfizer Inc. · 2004
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994